These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9124865

  • 1. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.
    Brandt CM, Warner CB, Rouse MS, Steckelberg JM, Wilson WR.
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865
    [Abstract] [Full Text] [Related]

  • 2. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J, Pahissa A, Almirante B, Laguarda M, Crespo E, Pou L, Fernández F.
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus viridans].
    Gavaldà J, Pahissa A, Almirante B.
    Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):174-6. PubMed ID: 8011732
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F, Martín-Luengo F, García A, Valdés M.
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [Abstract] [Full Text] [Related]

  • 5. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.
    Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, Dismukes W, Drew RH, Durack DT.
    Clin Infect Dis; 1998 Dec; 27(6):1470-4. PubMed ID: 9868662
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci.
    Henry NK, Wilson WR, Roberts RB, Acar JF, Geraci JE.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):465-7. PubMed ID: 3777910
    [Abstract] [Full Text] [Related]

  • 7. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F, Martín Luengo F, Valdés M.
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
    Entenza JM, Caldelari I, Glauser MP, Moreillon P.
    J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278
    [Abstract] [Full Text] [Related]

  • 9. Penicillin therapy for treatment of experimental endocarditis caused by viridans streptococci in animals.
    Wilson WR, Zak O, Sande MA.
    J Infect Dis; 1985 Jun; 151(6):1028-33. PubMed ID: 3846608
    [Abstract] [Full Text] [Related]

  • 10. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
    Martínez F, Martín-Luengo F, Garcia A, Valdés M.
    J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813
    [Abstract] [Full Text] [Related]

  • 11. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
    Saleh-Mghir A, Cremieux AC, Vallois JM, Muffat-Joly M, Devine C, Carbon C.
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2403-7. PubMed ID: 1489184
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis.
    Enzler MJ, Rouse MS, Henry NK, Geraci JE, Wilson WR.
    J Infect Dis; 1987 May; 155(5):954-8. PubMed ID: 3644854
    [Abstract] [Full Text] [Related]

  • 13. Treatment with various antibiotics of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
    Martínez F, Martín-Luengo F, García A, Valdés M.
    Eur Heart J; 1995 May; 16(5):687-91. PubMed ID: 7588902
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis.
    Brennan RO, Durack DT.
    Antimicrob Agents Chemother; 1983 Feb; 23(2):273-7. PubMed ID: 6838188
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [Abstract] [Full Text] [Related]

  • 16. Penicillin tolerance in experimental streptococcal endocarditis.
    Pulliam L, Inokuchi S, Hadley WK, Mills J.
    Lancet; 1979 Nov 03; 2(8149):957. PubMed ID: 91047
    [No Abstract] [Full Text] [Related]

  • 17. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
    Shelburne SA, Greenberg SB, Aslam S, Tweardy DJ.
    J Infect; 2007 Feb 03; 54(2):e99-101. PubMed ID: 16824611
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
    Gavaldà J, López P, Martín T, Gomis X, Ramírez JL, Azuaje C, Almirante B, Pahissa A.
    Antimicrob Agents Chemother; 2002 Feb 03; 46(2):378-84. PubMed ID: 11796345
    [Abstract] [Full Text] [Related]

  • 19. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.
    Blatter M, Fluckiger U, Entenza J, Glauser MP, Francioli P.
    Antimicrob Agents Chemother; 1993 Sep 03; 37(9):1971-6. PubMed ID: 8239615
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J, Onrubia PL, Gómez MT, Gomis X, Ramírez JL, Len O, Rodríguez D, Crespo M, Ruíz I, Pahissa A.
    J Antimicrob Chemother; 2003 Sep 03; 52(3):514-7. PubMed ID: 12917251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.